跳至主要内容
临床试验/CTRI/2026/01/101884
CTRI/2026/01/101884尚未招募Phase 3 4

An Open Label Controlled Clinical Trial For Comparative Analysis Of The Effect Of Standard Drug With Tablet Aurosickle In The Management Of Sickle Cell Disease In School Going Children.

Parul Institute Of Ayurveda Vadodara Gujarat1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月5日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

The volunteers will be informed about the study protocol Willing participants will be selected  The clinical research format will be prepared and validated Prior to the study approval will be taken from IEC PIA Parul university vadodara  and CTRI registration will be done  After selection each participant will be tested individually and selected according to selection criteria  Participant will be divided in two groups one group will receive Aurosickle tablet and another group will receive Ibuprofen tablet  it will include 6 week  treatment and follow up

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • Confirmed diagnosis of SCD Recent history of pain crisis often defined as more 2-3 episodes in the past year Current vaso-occlusive pain requiring hospitalisation or outpatient management.

排除标准

  • Age less than 3 years and greater than 16 years Pain associated with acute chest syndrome respiratory distress deep vein thrombosis pulmonary embolism gall bladder disease neuropathic pain etc Infections such as osteomyelitis septic arthritis pneumonia or other infections.

研究者

发起方
Parul Institute Of Ayurveda Vadodara Gujarat
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Toshi Patidar

Parul Institute Of Ayurveda Vadodara Gujarat

研究点 (1)

Loading locations...

相似试验